Allogene Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC ALLO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,355,809

Value ($000)

1,857

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,857	0.0%	1,355,809	12/31/2025
2025 Q3	11/10/2025	1,445	0.0%	1,165,280	9/30/2025
2025 Q2	8/12/2025	1,393	0.0%	1,232,535	6/30/2025
2025 Q1	9/15/2025	1,688	0.0%	1,155,844	3/31/2025
2024 Q4	2/6/2025	2,532	0.0%	1,188,838	12/31/2024
2024 Q3	11/12/2024	3,301	0.0%	1,178,848	9/30/2024
2024 Q2	8/12/2024	2,746	0.0%	1,178,401	6/30/2024
2024 Q1	5/9/2024	3,837	0.0%	858,476	3/31/2024
2023 Q4	2/6/2024	2,352	0.0%	732,835	12/31/2023
2023 Q3	11/8/2023	2,477	0.0%	781,328	9/30/2023
2023 Q2	8/10/2023	3,307	0.0%	665,331	6/30/2023
2023 Q1	5/12/2023	3,212	0.0%	650,285	3/31/2023
2022 Q4	2/13/2023	4,081	0.0%	648,795	12/31/2022
2022 Q3	11/14/2022	6,863	0.0%	635,455	9/30/2022
2022 Q2	8/15/2022	6,203	0.0%	544,109	6/30/2022
2022 Q1	5/13/2022	4,835	0.0%	530,659	3/31/2022
2021 Q4	2/11/2022	8,013	0.0%	537,045	12/31/2021
2021 Q3	11/16/2021	13,647	0.0%	530,996	9/30/2021
2021 Q2	8/16/2021	16,545	0.0%	634,369	6/30/2021
2021 Q1	5/17/2021	19,876	0.0%	563,054	3/31/2021
2020 Q4	2/16/2021	13,883	0.0%	550,007	12/31/2020
2020 Q3	11/13/2020	20,359	0.0%	539,883	9/30/2020
2020 Q2	8/20/2020	22,732	0.0%	530,866	6/30/2020
2020 Q1	5/15/2020	7,818	0.0%	402,153	3/31/2020
2019 Q4	2/7/2020	10,274	0.0%	395,447	12/31/2019